Modern Life Pharma GmbH

Modern Life Pharma

MAH & Licensing

From Products to Pharmaceutical Assets.

Modern Life Pharma GmbH evaluates and develops selected pharmaceutical opportunities through licensing, dossier access, market-specific rights, regulatory structures and long-term commercialization partnerships.

Discuss a Licensing Opportunity

Submit a Product or Dossier

MAH and Licensing

Building Value Beyond Distribution

Building Value Beyond Distribution

Modern Life Pharma approaches pharmaceutical partnerships with a long-term perspective. Depending on the product, territory and regulatory framework, opportunities may involve product licensing, dossier access, commercialization rights, regulatory coordination, MAH-related structures or broader portfolio development. Our objective is to identify structures that create sustainable value for both product owners and market partners.

Modern Life Pharma approaches pharmaceutical partnerships with a long-term perspective. Depending on the product, territory and regulatory framework, opportunities may involve product licensing, dossier access, commercialization rights, regulatory coordination, MAH-related structures or broader portfolio development. Our objective is to identify structures that create sustainable value for both product owners and market partners.

Product Licensing

We evaluate selected pharmaceutical products and portfolios for licensing and market-specific development. Potential structures may include exclusive or selected territorial rights, commercialization rights, supply-linked licensing, portfolio-based licensing and long-term product development arrangements.

Discuss a Product

Dossier Licensing & Acquisition

Modern Life Pharma reviews selected pharmaceutical dossiers that may be suitable for licensing, acquisition or market-specific regulatory development. Evaluation may consider dossier completeness, regulatory suitability, manufacturing source, target market potential, supply continuity and commercial viability.

Submit a Dossier Opportunity

MAH Partnerships

MAH Partnerships

Modern Life Pharma evaluates appropriate MAH and regulatory ownership structures based on the product, jurisdiction, regulatory pathway and commercial model. Where specialized regulatory capabilities are required, we work with qualified regulatory and manufacturing partners.

Modern Life Pharma evaluates appropriate MAH and regulatory ownership structures based on the product, jurisdiction, regulatory pathway and commercial model. Where specialized regulatory capabilities are required, we work with qualified regulatory and manufacturing partners.

01 · Product

02 · Regulatory Assessment

03 · Appropriate MAH Structure

04 · Registration Development

05 · Commercialization

06 · Lifecycle Management

Portfolio Development

Beyond individual products, Modern Life Pharma evaluates opportunities to build selected therapeutic and commercial portfolios across targeted international markets. Focus may include product families, selected therapeutic portfolios, market-specific rights and long-term supply and licensing combinations.

Commercial Rights

Commercial structures are developed according to the product, market, regulatory requirements and long-term objectives of the partnership. Potential arrangements may include market-specific commercialization rights, distribution-linked rights, selected territorial rights, portfolio development rights and structured long-term supply relationships.

Lifecycle Development

Lifecycle Development

Long-term pharmaceutical value extends beyond initial registration and launch. Where relevant, Modern Life Pharma supports coordination across regulatory maintenance, variations, product extensions, packaging and market adaptation, supply continuity, portfolio evolution and commercial lifecycle planning.

Long-term pharmaceutical value extends beyond initial registration and launch. Where relevant, Modern Life Pharma supports coordination across regulatory maintenance, variations, product extensions, packaging and market adaptation, supply continuity, portfolio evolution and commercial lifecycle planning.

How We Evaluate Opportunities

How We Evaluate Opportunities

Each opportunity is evaluated individually according to regulatory, commercial, supply and market considerations.

Each opportunity is evaluated individually according to regulatory, commercial, supply and market considerations.

01
Product & Portfolio Review

02
Regulatory Assessment

03
Market Fit

04
Commercial Structure

05
Partner Alignment

06
Long-Term Development

Who We Work With

Who We Work With

Pharmaceutical Manufacturers

Product & Dossier Owners

Regulatory Partners

Commercial & Distribution Partners

Modern Life Pharma works selectively with partners capable of supporting reliable, compliant and sustainable pharmaceutical development.

Modern Life Pharma works selectively with partners capable of supporting reliable, compliant and sustainable pharmaceutical development.

A Structured Partnership Approach

A Structured Partnership Approach

Modern Life Pharma does not rely on a single partnership model. The appropriate structure is determined by the product, market, regulatory framework and long-term commercial objective. Where specialized manufacturing, regulatory or technical capabilities are required, we work with qualified partner organizations.

Modern Life Pharma does not rely on a single partnership model. The appropriate structure is determined by the product, market, regulatory framework and long-term commercial objective. Where specialized manufacturing, regulatory or technical capabilities are required, we work with qualified partner organizations.

Have a Product, Portfolio or Dossier Opportunity?

We welcome confidential discussions with manufacturers, product owners and pharmaceutical partners exploring licensing, market access and long-term development opportunities.

We welcome confidential discussions with manufacturers, product owners and pharmaceutical partners exploring licensing, market access and long-term development opportunities.

Discuss an Opportunity

Submit a Dossier or Portfolio

Modern Life Pharma GmbH
Schillerstraße 2 · 89077 Ulm · Germany

www.modernlifepharma.de

Contact

Impressum

Privacy Policy